"RDIF announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of the Republic of Cameroon. Thus Sputnik V is approved for use in 53 countries with a total population of over 1.4 billion people," the press release read.
"Africa is among the leaders in terms of the number of approvals of Sputnik V. We welcome the decision of the Ministry of Health of Cameroon which will help the population of the country to obtain access to one of the best solutions against coronavirus in the world," RDIF CEO Kirill Dmitriev noted, as quoted in the press release.
In February, the peer-reviewed medical journal, The Lancet, published an interim analysis from the Phase III clinical trials of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19.
Developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V became the world's first officially-registered vaccine against COVID-19.